Poor Sleep
Sanofi India Limited and Cipla Limited have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium®, a leading brand in the anti-epileptic medication category.
While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.
The Lancet Diabetes & Endocrinology Commission, a group of 58 leading experts from various medical…
Recently, an 8-year-old student of class 3 died due to cardiac arrest in her school…
Ahead of the Union Budget for the financial year 2025-26 to be presented by on…
A novel and innovative technique has been found by scientists that could curb the spread…
A recent study has revealed that a big glass of milk every day can help…